EcoDrugPlus

Catechol-O-Methyltransferase B

Ensembl ID : ENSAPEG00000023151
Gene Symbol: COMTB
1 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSAPEG00000016927
Gene Symbol: CTSC
1 Cross references
239 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSAPEG00000001951
Gene Symbol: CTSK
1 Cross references
226 Possible Orthologues:

Cathepsin S, Ortholog2, Tandem Duplicate 1

Ensembl ID : ENSAPEG00000001914
Gene Symbol: CTSS2.1
1 Cross references
235 Possible Orthologues:

Cell Division Cycle 7 Homolog (S. Cerevisiae)

Ensembl ID : ENSAPEG00000014481
Gene Symbol: CDC7
1 Cross references
209 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSAPEG00000023791
Gene Symbol: CHEK1
1 Cross references
179 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSAPEG00000023750
Gene Symbol: CHEK2
1 Cross references
206 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9a

Ensembl ID : ENSAPEG00000002045
Gene Symbol: CCR9A
1 Cross references
190 Possible Orthologues:

Chemokine (C-X-C Motif) Receptor 4a

Ensembl ID : ENSAPEG00000011520
Gene Symbol: CXCR4A
1 Cross references
216 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSAPEG00000005946
Gene Symbol: CCKAR
2 Cross references
201 Possible Orthologues:

Cholecystokinin B Receptor A

Ensembl ID : ENSAPEG00000017842
Gene Symbol: CCKBRA
1 Cross references
198 Possible Orthologues:

Cholesteryl Ester Transfer Protein, Plasma

Ensembl ID : ENSAPEG00000008965
Gene Symbol: CETP
1 Cross references
151 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).